Navigation Links
Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company
Date:9/27/2010

em.

VaxDesign is the developer of the Modular IMmune In-vitro Construct (MIMIC(R)) technology that melds immunology with engineering to find solutions to complex biological problems. The system is built to capture genetic and environmental diversity and based on data generated in a surrogate human immune system, provides earlier selection of the optimal product candidate as opposed to using animal models before studies in human clinical trials. MIMIC(R) will be relevant in the assessment of the value of Sanofi Pasteur's vaccine candidates, providing a key "filter" in the preclinical stage for a "go/no go" decision-making process before Phase I human clinical trials.

Under the terms of the agreement, Sanofi Pasteur will make an upfront payment of US $55 million upon closing of the transaction and an additional US $5 million upon realization of a certain development step. The closing of the transaction is expected to occur by the end of 2010, subject to customary conditions precedent.

"MIMIC(R) is the most-advanced platform in the field," declared Michel DeWilde, Ph.D., Senior Vice President, Research and Development, Sanofi Pasteur. "With this novel model for understanding mechanisms of action, the probability of clinical success increases and the time to market should decrease. MIMIC(R) successfully reproduced our own clinical data and is adaptable for the evaluation of multiple diseases and corresponding patient populations. This platform will provide a significant competitive advantage in the development of vaccines."

"We are excited and appreciative to be part of the Sanofi Pasteur legacy of innovation," said VaxDesign's President & CEO William Warren, Ph.D. "The acquisition enables us to leave an imprint on public health through concrete applications of the immune system in a test tube."

About VaxDesign

VaxDesign, is a privately held U.S. biotechnology company, based in Orlando, F
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
2. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
3. Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants
4. AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
5. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis
6. Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
7. Sanofi Pasteur Receives Seed Virus to Produce New Influenza A(H1N1) Vaccine
8. Sanofi-aventis U.S. Announces Settlement of Medicaid Best Price Investigation
9. Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply
10. Sanofi-aventis Announces Second Quarter 2009 Results
11. Sanofi-aventis U.S. Introduces BenzaClin(R) Carekit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... PA (PRWEB) July 22, 2014 Two ... Center’s Board of Directors at its annual Shareholders Meeting ... Chief Information Officer of The PFM Group, and Stephen ... Science Center also announced the election of Michael A. ... Board Vice Chair and Richard P. Jaffe, Esq., of ...
(Date:7/22/2014)... , Cina, 22 luglio 2014 BGI ... BGI, la maggiore organizzazione di genomica del mondo, ha ... sequenziamento dell,intero esoma umano con base la piattaforma leader ... Genomics, molto apprezzata nel settore per essere in grado ... di precisione e una rilevazione altamente sensibile di tutti ...
(Date:7/22/2014)... 2014 In chemical and petrochemical ... common sight. The rapid rise of TDL analyzers ... established as a core gas measurement technology, and ... them the gas analyzer technology of choice for ... in some processes have limited their application range. ...
(Date:7/22/2014)... SPRING, Md. , July 22, 2014 /PRNewswire/ ... announced today that it will release its second ... Tuesday, July 29, 2014. United Therapeutics ... 29, 2014, at 9:00 a.m. Eastern Time.  The ... callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
Breaking Biology Technology:Two New Members Elected to University City Science Center Board of Directors 2Two New Members Elected to University City Science Center Board of Directors 3BGI Tech lancia un servizio di sequenziamento dell'intero esoma umano sulla piattaforma avanzata di Complete Genomics 2METTLER TOLEDO Shows How Tunable Diode Lasers (TDLs) Can Be Installed Where No TDLs Have Gone Before 2
... May 24, 2011 Benefiting from recent investments in production ... just reported another record quarter. The leading developer of topical ... up 126 percent over Q1 of 2010. It was the ... year ago. "Although Q1 delivered a stellar ...
... 2011 Radius Health, Inc. ("Radius") today announced that ... third financing round, including $66 million in equity financing ... and Oxford Finance LLC to a $25 million multi-draw ... AG, Brookside Capital, Saints Capital, Nordic Bioscience ("Nordic"), and ...
... A protein isolated from beneficial bacteria found in yogurt ... option for inflammatory bowel disorders (IBD), suggests a study ... M.D., Ph.D. The study, published May 23 in ... the protein, called p40, was effective as an intervention ...
Cached Biology Technology:First-quarter 2011 Sales Reach $2.25M — 126% Growth Over Q1 of 2010 — for Biotech Developer Divine Skin 2First-quarter 2011 Sales Reach $2.25M — 126% Growth Over Q1 of 2010 — for Biotech Developer Divine Skin 3Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 2Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 3Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 4Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 5Protein from probiotic bacteria may alleviate inflammatory bowel disorders 2Protein from probiotic bacteria may alleviate inflammatory bowel disorders 3
(Date:7/22/2014)... box and you,re likely to find that the lunches and ... findings of a study conducted by researchers at the Friedman ... in the Department of Public Health and Community Medicine at ... online ahead of print in the Journal of the ... senior author Jeanne Goldberg, Ph.D., R.D., a professor at the ...
(Date:7/22/2014)... 22, 2014, Cleveland: A type of immune cell ... such as Alzheimer,s disease and multiple sclerosis (MS), ... injury (TBI) and may slow the progression of ... today in the online journal Nature Communications ... Trapp, PhD, Chair of the Department of Neurosciences ...
(Date:7/21/2014)... Middle East Respiratory Syndrome coronavirus (MERS-CoV) in the air ... virus. The work, published this week in mBio ... for Microbiology, indicates that further studies are needed to ... air. , MERS, a serious viral respiratory illness caused ... as of June 11, according to the World Health ...
Breaking Biology News(10 mins):Room for improvement in elementary school children's lunches and snacks from home 2Cleveland Clinic researchers discover neuroprotective role of immune cell 2Middle East Respiratory Syndrome coronavirus detected in the air of a Saudi Arabian camel barn 2
... complaint against British drug maker GlaxoSmithKline (GSK) over its ... proceed following an order late last week by South ... go forward. GSK has sought outright dismissal of the ... week giving the complainants, AIDS Healthcare Foundation (AHF) and ...
... apples might do a better job of keeping the ... analyzed eight popular varieties of the fruit. Red Delicious, ... greater wallop of disease-fighting antioxidants than other apples studied. ... Agriculture and Agri-Food Canada in Guelph, Ontario, also pinpointed ...
... of an anti-inflammatory drug eliminated all of the cancer-causing ... when several genetic brakes to cancer formation were missing ... Cancer Center. , The investigators, who presented their findings ... for Cancer Research, say that while the results do ...
Cached Biology News:South African Tribunal Asks For Damages Estimates in GSK AIDS Drug Case 2Red delicious, Northern Spy apples have most antioxidants, chemists find 2NSAID drug protects against intestinal tumors in mice, despite poor diet and gene losses 2NSAID drug protects against intestinal tumors in mice, despite poor diet and gene losses 3
... muscle cell specific protein, is reported to be ... as intestine, lung and uterus. It shares structural ... expression has been reported in most tissues that ... forms. It is also reported to be expressed ...
PC based system for superior chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
Request Info...
... Round Well Plate Sterile ... wide range of 384-well ... high-throughput screening and research. ... assays and are suitable ...
Biology Products: